Surgery Partners Inc

Surgery Partners Inc(SGRY)股票分析

$13.690

-0.235 (-1.72%)收盘时

Loading chart…
High
13.980
Open
13.870
VWAP
13.73
Vol
2.04M
Mkt Cap
3.09B
Low
13.515
Amount
27.99M
EV/EBITDA, TTM
9.52

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals.

AI analysis of Surgery Partners Inc (SGRY)

hold

Surgery Partners Inc is currently a hold. The stock is priced at $13.69, which is significantly below the analyst price targets of $18 and $19, indicating potential upside. However, the RSI is at 32.53, suggesting the stock is oversold, and the recent insider selling has increased by 258.25%, which raises concerns about management's confidence. The company is also facing a challenging financial environment with a year-to-date change of -10.29% and a one-year change of -39.37%.

Analyst Ratings (9)

+92.11% upside
Buy
4 Buy
4 Hold
1 Sell
Current: 13.69
最低
18.00
平均
26.30
最高
36.00

RBC Capital

2026-08-11

目标价

$19

Outperform

TD Cowen

2026-08-11

目标价

$19

Buy

Cantor Fitzgerald

2026-08-11

目标价

$18

Overweight

Jefferies

2026-05-06

目标价

$17

Buy

Jefferies

2026-04-20

目标价

$15

Buy

估值指标

The current forward P/E ratio for Surgery Partners Inc (SGRY) is 24.21, compared to its 5-year average forward P/E of -35.11.

Forward P/E

Fair
5Y Average P/E
-35.11
Current P/E
24.21
高估
828.39
低估
-898.60

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
16.03
Current EV/EBITDA
9.52
高估
20.31
低估
11.75

Forward P/S

Undervalued
5Y Average P/S
1.12
Current P/S
0.51
高估
1.53
低估
0.71

Alphio AI Price Scenarios for SGRY

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SGRY

$22.84

情景价格

B

Base

Base · 50%SGRY

$21.90

情景价格

B

Bear

Bear · 25%SGRY

$21.04

情景价格

Whales holding SGRY

J

Jaunty Global Limited

+ HoldingSGRY

+4.05%

3M Return

P

Pentwater Capital Management LP

+ HoldingSGRY

-6.60%

3M Return

D

Davidson Kempner Capital Management LP

+ HoldingSGRY

-18.00%

3M Return

事件时间线

2026-08-23 (ET)

00:00:00

Charter Communications Short Interest Rises to 32.4%

2026-08-10 (ET)

17:00:00

Stocks Open Lower as Middle East Uncertainty Grows

12:30:00

Major Averages Mixed at Open Amid Middle East Uncertainty

08:00:00

Company Reports Q2 Revenue of $848.9M, Exceeds Expectations

08:00:00

Company Reaffirms 2026 Revenue Outlook of $3.35B to $3.45B

资讯

SGRY FAQ — answered by Alphio AI

Surgery Partners, Inc. is a healthcare services company. The Company, through its subsidiaries, owns and operates a national network of surgical facilities and ancillary services. The Company operates through the Surgical Facility segment, which includes the operation of ambulatory surgery centers (ASCs), surgical hospitals, anesthesia services, urgent care facilities and multi-specialty physician practices. Its surgical facilities primarily provide non-emergency surgical procedures across many specialties, including, among others, orthopedics and pain management, ophthalmology, gastroenterology (GI) and general surgery. The Company operates a portfolio of approximately 162 surgical facilities comprised of 175 ASCs and 19 surgical hospitals. The Company is focused on surgical services businesses in the United States, with over 200 locations in 30 states, including short-stay surgical hospitals. It operates in the Healthcare sector (SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC industry).

Surgery Partners Inc is currently a hold. The stock is priced at $13.69, which is significantly below the analyst price targets of $18 and $19, indicating potential upside. However, the RSI is at 32.53, suggesting the stock is oversold, and the recent insider selling has increased by 258.25%, which raises concerns about management's confidence. The company is also facing a challenging financial environment with a year-to-date change of -10.29% and a one-year change of -39.37%.

9 analysts cover SGRY: 4 rate it Buy, 4 Hold and 1 Sell. The average price target is 26.30.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始